Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In Vitro Susceptibility of Fusarium to Isavuconazole

25 Nov 2019

Abstract excerpt

To evaluate the in vitro susceptibility of Fusarium to isavuconazole, 75 clinical isolates were identified using matrix-assisted laser desorption ionization–time of flight mass spectrometry and then tested with a broth microdilution method (EUCAST) and the gradient concentration strip (GCS) technique. The activity of isavuconazole overall was shown to be limited, with an MIC 50 of >16 μg/ml, without significant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal resistance and susceptibility
Share to Mycotoxins in Agriculture and Food
Share to Plant Pathogens and Fungal Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31767726
DOI: 10.1128/aac.01621-19

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In Vitro Susceptibility of Fusarium to IsavuconazolePMID 31767726Read ↗

Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complexSemantic proximity Read ↗

Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolatesSemantic proximity Read ↗

Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method.Semantic proximity Read ↗

EUCAST Susceptibility Testing of Isavuconazole: MIC Data for Contemporary Clinical Mold and Yeast IsolatesSemantic proximity Read ↗

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2005: an 8.5-Year Analysis of Susceptibilities of <i>Candida</i> Species and Other Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion TestingSemantic proximity Read ↗

Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method.Semantic proximity Read ↗

In Vitro Antifungal Susceptibility of Clinically Relevant Species Belonging to Aspergillus Section FlaviSemantic proximity Read ↗

Aspergillus Section Terrei and Antifungals: From Broth to Agar-Based Susceptibility Testing MethodsSemantic proximity Read ↗

EUCAST Determination of Olorofim (F901318) Susceptibility of Mold Species, Method Validation, and MICsSemantic proximity Read ↗

In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.Semantic proximity Read ↗

Multicentric Analysis of the Species Distribution and Antifungal Susceptibility of Cryptic Isolates from Aspergillus Section FumigatiSemantic proximity Read ↗

Luliconazole, a New Antifungal, vs Amphotericin B, Voriconazole, Posaconazole and Caspofungin against Clinical and Environmental <i>Aspergillus</i> Nigri ComplexSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.